Stock A263050 EUTILEX.CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Eutilex.Co.,Ltd

Equities

A263050

KR7263050007

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 27/05/2024 BST 		5-day change 1st Jan Change
1,943 KRW -0.46% Intraday chart for Eutilex.Co.,Ltd -11.68% -42.51%
05-16 Eutilex.Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-21 Eutilex.Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Eutilex Co., Ltd. is a Korea-based company mainly engaged in the production and sale of immunotherapy products. Major products include anticancer T cell therapies and antibody therapies.

Sales per Business

KRW in Million2022Weight2023Weight Delta
T-cell Therapy and Antibody Therapeutics
100.0 %
216 100.0 % 132 100.0 % -38.95%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
70.1 %
216 100.0 % 92 70.1 % -57.18%
China
29.9 %
-- 39 29.9 % -

Managers

Managers TitleAgeSince
Soo-Young Choi CEO
 Chief Executive Officer 63 29/02/20
Byoung Kwon FOU
 Founder 77 26/02/15
Guk-Hee Lee AUD
 Comptroller/Controller/Auditor 76 30/11/16
Young-Ho Kim PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Yong-Sang Cho BRD
 Director/Board Member 76 27/12/18
Byoung Kwon FOU
 Founder 77 26/02/15
Myung-Hee Han BRD
 Director/Board Member 76 27/12/18
Young-Ho Kim PRN
 Corporate Officer/Principal - -
Bin Heo BRD
 Director/Board Member 48 -
Jang-Woo Park BRD
 Director/Board Member 75 28/02/18
Soo-Young Choi CEO
 Chief Executive Officer 63 29/02/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 47,471 0 2 ( 0.004213 %) 70.21 %
Stock B 1 36,798,858 25,836,762 ( 70.21 %) 0

Shareholders

NameEquities%Valuation
Byoung Kwon
10.90 %
4,006,860 10.90 % 6 M ₩
Myung-Hee Han
1.588 %
583,634 1.588 % 933 242 ₩
Hyung-joong Kwon
0.6855 %
251,992 0.6855 % 402 940 ₩
Yoo-joong Kwon
0.6855 %
251,992 0.6855 % 402 940 ₩
Myung-joong Kwon
0.6855 %
251,992 0.6855 % 402 940 ₩
EUTILEX.CO.,LTD
0.0108 %
3,977 0.0108 % 6 359 ₩
Mirae Asset Global Investments Co., Ltd.
0.000250 %
92 0.000250 % 147 ₩
Young-Ho Kim
0.000000 %
0 0.000000 % - ₩
NameEquities%Valuation
EUTILEX.CO.,LTD
0.000067 %
2 0.000067 % 3 ₩

Holdings

NameEquities%Valuation
EUTILEX.CO.,LTD
0.01%
 3,977 0.01% 6,359 $

Company contact information

Eutilex Co., Ltd.

Suite 408 58 Gasan digital 1-ro

08591, Seoul

+

http://www.eutilex.com
address Eutilex.Co.,Ltd(A263050)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
EUTILEX.CO.,LTD Stock Eutilex.Co.,Ltd
-42.51% 52.62M
CSL LIMITED Stock CSL Limited
-2.95% 90.75B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-1.97% 39.03B
BIOGEN INC. Stock Biogen Inc.
-15.47% 31.85B
UCB Stock UCB
+61.34% 26.26B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-22.81% 14.13B
INCYTE CORPORATION Stock Incyte Corporation
-8.82% 12.87B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.77% 11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-45.97% 10.91B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+3.07% 8.89B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A263050 Stock
  4. Company Eutilex.Co.,Ltd